Both in Pharmaceuticals
Cronos Group Inc. Common Share vs Rapport Therapeutics
Over the past year CRON returned +34.5% and RAPP returned −22.3%; their daily moves had a correlation of 0.17.
CRON +34.5% RAPP −22.3%Growth of $1, one year, split-adjusted
| Metric | CRON | RAPP |
|---|---|---|
| Price | $3.35 | $22.50 |
| Market cap | $1.23B | $1.08B |
| Today | −0.89% | −18.30% |
| 1 month | −0.9% | −31.9% |
| 6 months | +29.8% | −31.8% |
| Year to date | +27.4% | −25.8% |
| 1 year | +35.6% | −15.0% |
| Revenue growth (YoY) | +59.5% | — |
| Gross margin | 65.8% | — |
| Net margin | 45.4% | — |
| P/E (TTM) | 17.6× | — |
| Price / sales | 4.8× | 54.0× |
| Net cash | $797.0M | $436.1M |
| Dividend yield | — | — |
| Volatility (60d) | 39.0% | 80.1% |
| Short % of float | 2.1% | 10.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).